Rift Valley fever: Wageningen University awarded $12.5 million to develop human vaccine
by Press Release from Outbreak News Today on (#4JY67)
Wageningen Bioveterinary Research (WBVR), part of Wageningen University & Research, and the Coalition for Epidemic Preparedness Innovations (CEPI) hereby announce a new partnering agreement. With support from the European Union's (EU's) Horizon 2020 programme, CEPI will provide up to US$12.5 million for vaccine manufacturing, preclinical research, and a phase 1 study to assess the safety, ["]
The post Rift Valley fever: Wageningen University awarded $12.5 million to develop human vaccine appeared first on Outbreak News Today.